SE405253B - Sett att framstella 5-azapyrimidinnukleosider - Google Patents

Sett att framstella 5-azapyrimidinnukleosider

Info

Publication number
SE405253B
SE405253B SE7103210A SE321071A SE405253B SE 405253 B SE405253 B SE 405253B SE 7103210 A SE7103210 A SE 7103210A SE 321071 A SE321071 A SE 321071A SE 405253 B SE405253 B SE 405253B
Authority
SE
Sweden
Prior art keywords
producing
methods
azapyrimidine
nucleosides
azapyrimidine nucleosides
Prior art date
Application number
SE7103210A
Other languages
English (en)
Inventor
H Vorbruggen
U Niedballa
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of SE405253B publication Critical patent/SE405253B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/12—Triazine radicals
SE7103210A 1970-03-14 1971-03-12 Sett att framstella 5-azapyrimidinnukleosider SE405253B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2012888A DE2012888C3 (de) 1970-03-14 1970-03-14 Verfahren zur Herstellung von 5-Azapyrimidinnucleosiden

Publications (1)

Publication Number Publication Date
SE405253B true SE405253B (sv) 1978-11-27

Family

ID=5765475

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7103210A SE405253B (sv) 1970-03-14 1971-03-12 Sett att framstella 5-azapyrimidinnukleosider

Country Status (19)

Country Link
US (1) US3817980A (sv)
JP (1) JPS5527077B1 (sv)
AT (1) AT313481B (sv)
BE (1) BE764179A (sv)
CA (1) CA946379A (sv)
CH (1) CH552606A (sv)
CS (1) CS162741B2 (sv)
DE (1) DE2012888C3 (sv)
DK (1) DK152134C (sv)
ES (1) ES388193A1 (sv)
FI (1) FI56018C (sv)
FR (1) FR2085707B1 (sv)
GB (1) GB1351003A (sv)
HU (1) HU164144B (sv)
IL (1) IL36363A (sv)
NL (1) NL180835C (sv)
PL (1) PL81543B1 (sv)
SE (1) SE405253B (sv)
ZA (1) ZA711084B (sv)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1531469A (en) * 1975-12-18 1978-11-08 Farmaceutici Italia Daunosamine nucleosides
US4171431A (en) * 1976-08-19 1979-10-16 The Upjohn Company Nucleosides and process
DE2721466A1 (de) * 1977-05-12 1978-11-16 Robugen Gmbh Verfahren zur herstellung von 2'-desoxyribofuranosylnucleosiden
DE2757365A1 (de) * 1977-12-20 1979-06-21 Schering Ag Neues verfahren zur herstellung von nucleosiden
GB1601020A (en) 1978-04-24 1981-10-21 Stichting Grega Vzw 2'-deoxy-5 (2-halogenovinyl)-uridines
US4423212A (en) * 1980-12-18 1983-12-27 The Upjohn Company Nucleosides and process
US5099010A (en) * 1983-01-17 1992-03-24 Research Corporation Intermediates in the preparation of 3'-amino-2',3'-dideoxycytidine and the pharmacologically acceptable salts thereof
JPS60193997A (ja) * 1984-03-14 1985-10-02 Sumitomo Chem Co Ltd 新規シアノイミダゾ−ルリボヌクレオシド誘導体およびその製造法
US4730512A (en) * 1984-10-23 1988-03-15 Toyota Jidosha Kabushiki Kaisha Engine crankshaft structure
CA1301166C (en) * 1987-07-21 1992-05-19 John Nicholas Freskos Process for preparing 2-deoxynucleosides
US6982253B2 (en) * 2002-06-05 2006-01-03 Supergen, Inc. Liquid formulation of decitabine and use of the same
EP1545558A4 (en) * 2002-09-24 2010-02-17 Koronis Pharmaceuticals Inc 1, 3, 5-TRIAZINES FOR THE TREATMENT OF VIRAL DISEASES
AU2012209018B2 (en) * 2003-03-17 2015-04-02 Celgene International Sarl Methods for isolating crystalline Form I of 5-azacytidine
AU2013200662B2 (en) * 2003-03-17 2015-04-02 Celgene International Sarl Methods for isolating crystalline Form I of 5-azacytidine
US7038038B2 (en) * 2003-03-17 2006-05-02 Pharmion Corporation Synthesis of 5-azacytidine
US6943249B2 (en) * 2003-03-17 2005-09-13 Ash Stevens, Inc. Methods for isolating crystalline Form I of 5-azacytidine
US6887855B2 (en) 2003-03-17 2005-05-03 Pharmion Corporation Forms of 5-azacytidine
US20060014949A1 (en) * 2004-07-13 2006-01-19 Supergen Inc. Compositions and formulations of decitabine polymorphs and methods of use thereof
US20060128654A1 (en) * 2004-12-10 2006-06-15 Chunlin Tang Pharmaceutical formulation of cytidine analogs and derivatives
US20060128653A1 (en) * 2004-12-10 2006-06-15 Chunlin Tang Pharmaceutical formulation of decitabine
UA99308C2 (ru) * 2007-09-26 2012-08-10 Маунт Синай Скул Оф Медсин Аналог азацитидина и его применение
EP2050757A1 (en) * 2007-10-10 2009-04-22 Cilag AG Method of producing 2' -deoxy-5-azacytidine (Decitabine)
EP2048151A1 (en) * 2007-10-10 2009-04-15 Cilag AG Method for producing nucleosides by direct glycosylation of the nucleoside base
EP3782611B1 (en) * 2008-05-15 2022-07-06 Celgene Corporation Oral formulations of cytidine analogs and methods of use thereof
WO2010014883A2 (en) 2008-08-01 2010-02-04 Dr. Reddy's Laboratories Ltd. Azacitidine process and polymorphs
US20100035354A1 (en) * 2008-08-06 2010-02-11 Ettore Bigatti Process for preparing azacytidine intermediate
JP5650643B2 (ja) 2008-08-08 2015-01-07 サイノファーム タイワン リミテッド ５−アザシトシンヌクレオシド及びその誘導体の製造方法
RU2543348C2 (ru) 2009-03-23 2015-02-27 Эмбит Байосайенсиз Корпорейшн Способ лечения путем применения комбинированной терапии
US20100249394A1 (en) * 2009-03-26 2010-09-30 Albemarle Corporation Processes for producing decitabine
IT1399195B1 (it) 2010-03-30 2013-04-11 Chemi Spa Processo per la sintesi di azacitidina e decitabina
JP6289361B2 (ja) 2011-03-31 2018-03-07 セルジーン インターナショナル サルル ５−アザシチジンの合成
US9913822B2 (en) 2012-04-04 2018-03-13 Halozyme, Inc. Combination therapy with an anti-hyaluronan agent and therapeutic agent
CN103884809B (zh) * 2013-08-28 2016-01-27 鲁南制药集团股份有限公司 一种地西他滨中间体的分析检测方法
JP6162349B1 (ja) * 2016-04-21 2017-07-12 大原薬品工業株式会社 ５−アザシチジン類の糖部シリルエーテル誘導体
CN108226309B (zh) 2016-12-13 2020-06-16 江苏奥赛康药业有限公司 一种右丙亚胺的分析方法
CN108239128B (zh) 2016-12-23 2019-03-29 江苏奥赛康药业股份有限公司 β-核苷类化合物的制备方法
CN110128485B (zh) * 2018-02-09 2022-06-07 鲁南制药集团股份有限公司 一种阿扎胞苷的制备方法
US20190351031A1 (en) 2018-05-16 2019-11-21 Halozyme, Inc. Methods of selecting subjects for combination cancer therapy with a polymer-conjugated soluble ph20

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1244790B (de) * 1963-10-29 1967-07-20 Ceskoslovenska Akademie Ved Verfahren zur Herstellung des cancerostatisch wirksamen 5-Azacytidins
GB1050899A (sv) * 1963-12-22
US3328388A (en) * 1964-09-02 1967-06-27 Merck & Co Inc Arabinofuranosyl pyrimidines and methods of preparing same
US3346561A (en) * 1965-10-24 1967-10-10 Merck & Co Inc Pyrimidine 3-deoxynucleosides
US3531464A (en) * 1966-10-21 1970-09-29 Us Health Education & Welfare Alternative synthesis of 2'-deoxy-5-(trifluoromethyl)-uridine and the alphaanomer thereof
CH527207A (de) * 1968-05-08 1972-08-31 Ceskoslovenska Akademie Ved Verfahren zur Herstellung von 1-Glycosyl-5-azacytosinen
CH507969A (de) * 1968-11-12 1971-05-31 Ceskoslovenska Akademie Ved Verfahren zur Herstellung von 1-Glycosyl-5-azacytosinen
CH532062A (de) * 1968-11-13 1972-12-31 Ceskoslovenska Akademie Ved Verfahren zur Herstellung von 1-Glykosyl-5-azacytosinen

Also Published As

Publication number Publication date
GB1351003A (en) 1974-04-24
JPS5527077B1 (sv) 1980-07-17
CS162741B2 (sv) 1975-07-15
DK152134B (da) 1988-02-01
SU374828A3 (sv) 1973-03-20
FR2085707A1 (sv) 1971-12-31
CH552606A (de) 1974-08-15
DE2012888A1 (de) 1971-09-30
DE2012888B2 (de) 1980-07-10
FI56018B (fi) 1979-07-31
DE2012888C3 (de) 1981-04-02
US3817980A (en) 1974-06-18
BE764179A (fr) 1971-09-13
IL36363A0 (en) 1971-05-26
HU164144B (sv) 1973-12-28
ZA711084B (en) 1971-10-27
FR2085707B1 (sv) 1975-04-18
NL7103459A (sv) 1971-09-16
FI56018C (fi) 1979-11-12
IL36363A (en) 1974-05-16
ES388193A1 (es) 1973-05-01
AT313481B (de) 1974-02-25
NL180835C (nl) 1987-05-04
PL81543B1 (sv) 1975-08-30
DK152134C (da) 1988-08-01
NL180835B (nl) 1986-12-01
CA946379A (en) 1974-04-30

Similar Documents

Publication Publication Date Title
SE405253B (sv) Sett att framstella 5-azapyrimidinnukleosider
AT329120B (de) Vertikalsynchronisierschaltung
SE412586B (sv) Sett att framstella isoflavonderivat
SE399558B (sv) Sett att framstella cyklocytidinforeningar
SE400286B (sv) Sett att framstella bis-3,5-dioxopiperaziner
SE402123B (sv) Sett att framstella 7-amino-3-metylcefemforeningar
SE392103B (sv) Sett att framstella 1,2-bensisotiazolin-3-oner
SE391181B (sv) Sett att framstella kinazolinderivat
SE391337B (sv) Sett att framstella 2-substituerade adenosinderivat
SE384867B (sv) Sett att framstella 2-substituerade adenosinderivat
SE385893B (sv) Sett att framstella diakylxantin-derivat
SE382212B (sv) Sett att framstella dekahydroisokinolinderivat
SE389116B (sv) Sett att syntetisera pteridiner
SU442601A3 (ru) Способ получения производных азепина
IT944258B (it) Procedimento per produrre polibutadiene
SE403287B (sv) Sett att framstella 1-etyl-imidazoler med antimykotisk verkan
SE7511913L (sv) Forfarande for att framstella wellpapp
SU437304A3 (ru) Способ получения этилен-пропиленового сополимера
SU437310A3 (ru) Способ получения целлюлозы
SE383732B (sv) Sett att framstella alkalialuminiumalkoholater
SE394669B (sv) Sett att framstella 4-hydroxifenylglycin
SE390308B (sv) Sett att framstella substituerade kobamider
SE382810B (sv) Sett att framstella aminoisokinoliner
SE398105B (sv) Sett att framstella keramiska foremal
SE386443B (sv) Sett att framstella bensodiazepinderivat